Kevin M. Ryan

Active 1990–2024

89
Papers
23,113
Citations
67
h-index
88
i10-index

Citations

Citations per year for Kevin M. Ryan1928: 1 citations1992: 1 citations1997: 6 citations1998: 25 citations1999: 75 citations2000: 91 citations2001: 98 citations2002: 111 citations2003: 101 citations2004: 85 citations2005: 69 citations2006: 67 citations2007: 75 citations2008: 93 citations2009: 138 citations2010: 155 citations2011: 149 citations2012: 178 citations2013: 195 citations2014: 184 citations2015: 197 citations2016: 206 citations2017: 207 citations2018: 270 citations2019: 755 citations2020: 977 citations2021: 901 citations2022: 802 citations2023: 750 citations2024: 1,281 citations2025: 678 citations2026: 18 citations1929–1991: no citations, so these years are not shown1993–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,558 citing papers, 21.3% of this breakdownChina: 2,552 citing papers, 21.3% of this breakdownUnited Kingdom: 657 citing papers, 5.5% of this breakdownGermany: 502 citing papers, 4.2% of this breakdownItaly: 486 citing papers, 4.1% of this breakdownFrance: 460 citing papers, 3.8% of this breakdownJapan: 302 citing papers, 2.5% of this breakdownCanada: 296 citing papers, 2.5% of this breakdownIndia: 288 citing papers, 2.4% of this breakdownSpain: 261 citing papers, 2.2% of this breakdownAustralia: 250 citing papers, 2.1% of this breakdownSouth Korea: 221 citing papers, 1.8% of this breakdown
0%21.3%Other 26.3%

Fields

  • Medicine55%
  • Biochemistry, Genetics and Molecular Biology31.4%
  • Immunology and Microbiology4.9%
  • Engineering1.8%
  • Neuroscience1.4%
  • Materials Science1.4%
  • Other4.1%

Topics

  • Autophagy in Disease and Therapy11.7%
  • Cancer-related Molecular Pathways4.1%
  • Epigenetics and DNA Methylation2.8%
  • Cell death mechanisms and regulation2.3%
  • Cancer, Hypoxia, and Metabolism2.1%
  • Endoplasmic Reticulum Stress and Disease1.9%
  • Other75.1%

Coauthors

All papers

Open in search
  1. Autophagy and autophagy-related pathways in cancer

    Authors: , , - Nature Reviews Molecular Cell Biology 2023 cited by 1,326

  2. Autophagy in major human diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sharad Kumar, Carlos López-Otı́n, Kay F. Macleod, Frank Madeo, Jennifer Martinez, Alicia Meléndez, Noboru Mizushima, Christian Münz, Josef Penninger, Rushika M. Perera, Mauro Piacentini, Fulvio Reggiori, David C. Rubinsztein, Kevin M. Ryan, Junichi Sadoshima, Laura Santambrogio, Luca Scorrano, Hans‐Uwe Simon, Anna Katharina Simon, Anne Simonsen, Alexandra Stolz, Nektarios Tavernarakis, Sharon A. Tooze, Tamotsu Yoshimori, Junying Yuan, Zhenyu Yue, Qing Zhong, Lorenzo Galluzzi, Federico Pietrocola - The EMBO Journal 2021 cited by 1,549

  3. Molecular definitions of autophagy and related processes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frank Madeo, Sascha Martens, Jennifer Martinez, Alicia Meléndez, Noboru Mizushima, Christian Münz, Leon O. Murphy, Josef Penninger, Mauro Piacentini, Fulvio Reggiori, David C. Rubinsztein, Kevin M. Ryan, Laura Santambrogio, Luca Scorrano, Anna Katharina Simon, Hans‐Uwe Simon, Anne Simonsen, Nektarios Tavernarakis, Sharon A. Tooze, Tamotsu Yoshimori, Junying Yuan, Zhenyu Yue, Qing Zhong, Guido Kroemer - The EMBO Journal 2017 cited by 1,622

  4. Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis

    Authors: , , , , , , , , , , , , , - The EMBO Journal 2018 cited by 528

  5. Mannose impairs tumour growth and enhances chemotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature 2018 cited by 421

  6. Autophagy in malignant transformation and cancer progression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The EMBO Journal 2015 cited by 1,161

  7. D-mannose suppresses macrophage IL-1β production

    Authors: , , , , , , , , , - Nature Communications 2020 cited by 226

  8. Lysosome damage triggers direct ATG8 conjugation and ATG2 engagement via non-canonical autophagy

    Authors: , , , , , - The Journal of Cell Biology 2023 cited by 95

  9. Persistent endotheliopathy in the pathogenesis of long COVID syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Thrombosis and Haemostasis 2021 cited by 342

  10. DRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis

    Authors: , , , , , , , , , - Cell 2006 cited by 1,358

  11. p53 and metabolism

    Authors: , - Nature reviews. Cancer 2009 cited by 959

  12. p53 status determines the role of autophagy in pancreatic tumour development

    Authors: , , , , , , , , , , , , , , - Nature 2013 cited by 706

  13. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2017 cited by 256

  14. 50 years on and still very much alive: ‘Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics’

    Authors: , - British Journal of Cancer 2022 cited by 111

  15. The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2

    Authors: , , , , , , , , , , - The EMBO Journal 1998 cited by 1,168

  16. Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function

    Authors: , , , , , , , , , , , , , , - Molecular Cell 2017 cited by 242

  17. MCL-1 is a prognostic indicator and drug target in breast cancer

    Authors: , , , , , , , , , , , - Cell Death and Disease 2018 cited by 203

  18. Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Thrombosis and Haemostasis 2022 cited by 75

  19. Autophagy, the innate immune response and cancer

    Authors: , - Molecular Oncology 2020 cited by 95

  20. BRD4-mediated repression of p53 is a target for combination therapy in AML

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter D. Adams - Nature Communications 2021 cited by 78

  21. Lignin for energy applications – state of the art, life cycle, technoeconomic analysis and future trends

    Authors: , , , , , , , , , , , , , - Green Chemistry 2022 cited by 229

  22. Regulation and function of the p53 tumor suppressor protein

    Authors: , , - Current Opinion in Cell Biology 2001 cited by 723

  23. Autophagy Inhibition Mediates Apoptosis Sensitization in Cancer Therapy by Relieving FOXO3a Turnover

    Authors: , , , , , , , , , , - Developmental Cell 2018 cited by 206

  24. Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response

    Authors: , , , , , , , , , , , , , , , , - Journal of Thrombosis and Haemostasis 2021 cited by 234